May 17, 2009
New Frontiers in Hormone Therapy for Breast Cancer
Hormone therapy is a standard treatment for both early-stage and metastatic breast cancer. New studies show that extending the duration of treatment in post-menopausal women beyond the standard five years may reduce cancer recurrence and improve survival.
In this video, Dr. Hope Rugo discusses a promising new class of hormone treatments—Aromatase inhibitors—and how they may benefit patients when used either alone or in combination with the widely used breast cancer drug Tamoxifen.
Interviewee:
Hope S. Rugo, MD, Clinical Professor of Medicine; Director, Breast Oncology Clinical Trials Program, UCSF Helen Diller Family Comprehensive Cancer Center
Trackback
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341c0d2f53ef01156f9a0676970c
Listed below are links to weblogs that reference New Frontiers in Hormone Therapy for Breast Cancer:
Comments
RSS Feeds
BeetMedicine.TV Alerts
Featured on BeetMedicine.TV
- Michael Alvarado, MD - MD Breast Cancer Surgeon, UCSF
- Freya Schnabel, MD - Breast Surgeon, NYU Cancer Institute
- Julia A. Smith, MD, PhD - Medical Oncologist, NYU Cancer Institute
- Shelley Hwang MD, MPH - Chief Breast Surgical Oncology UCSF
- Elizabeth Poynor, MD, PhD - Gynecologic Oncologist
- Hope S. Rugo, MD - Director, Breast Oncology and Clinical Trials Education, UCSF
- Alison Jacoby, MD - Director Comprehensive Fibroid Center, UCSF
- Kathy Plesser, MD - Radiologist
- Virginia Wade, MD - Anesthesiologist
- Bonnie Reichman, MD - Medical Oncologist, Weill Cornell Medical College
- Mary S. Beattie, MD - Director of Clinical Research, UCSF Cancer Risk Program
- Amber Guth, MD - Breast Surgeon, NYU Cancer Institute
- Yelena Novik, MD - Medical Oncologist, NYU Cancer Institute
- Anne Moore, MD - Medical Oncologist, Weill Cornell Medical College
- Alexes Hazen, MD - Plastic Surgeon, NYU Cancer Institute
- Nolan Karp, MD - Plastic Surgeon, NYU Cancer Institute
- Mihye Choi, MD - Plastic Surgeon, NYU Cancer Institute
- Elissa Epel, PhD - Associate Professor, Department of Psychiatry, UCSF
- Deborah Axelrod, MD - Breast Surgeon, NYU Cancer Institute
- Beth Siegel, MD - Breast Surgeon, NYU Cancer Institute
- Peter Pressman, MD - Breast Surgeon, Weill Cornel Medical College
- Baljit Singh, MD - Pathologist, NYU Cancer Institute
- Shivani Nazareth, MS - Genetics Counselor, Weill Cornell Medical Center
- Kathy Plesser, MD, Radiologist
- Alex Swistel, MD - Breast Surgeon, Weill Cornell Medical Center
